| Debiopharm Group |
Dr. Mauvernay completed his medical studies at the Faculty of Medicine and Pharmacy at the University of Strasbourg, France and later obtained his Ph.D. in Biology, Bacteriology and Pharmacy. In 1953, he established RIOM Laboratories, in Auvergne, France and purchased several pharmaceutical laboratories and various rare molecules. In 1973, he sold RIOM and in 1979, founded Debiopharm S.A., a biopharmaceutical development company which fully funds and develops innovative therapeutics. He later created Debio R.P. S.A., specialising in the development of sustained-release advanced drug delivery systems and manufacturing. In 1993, he founded Debioclinic S.A., a clinical research organisation in Paris and in 2005, added Montreal-based Debiovision Inc. to the company. Today, Dr. Mauvernay heads a group of 300 employees, supported by 500 external experts, who are responsible for research and development.
Mr. Mauvernay received his Master of Science in Economics in 1975. He then obtained a degree from the 'Institut d'Administration des Entreprises’ and a ‘Diplôme d'Études Supérieures Spécialisées en Marketing’ in Clermont-Ferrand, France in 1976. In 1978, he founded an international cosmetics company, which he later sold but continued to manage until July 2001, when he joined Debiopharm S.A. as Executive Vice President with direct responsibilities for the Finance and Administration Department. In 2006, Mr Mauvernay handed over his operational activities within Debiopharm S.A. and has since been focusing on the administration, finance and strategy of Debiopharm Group. He is also administrator of the Debiopharm Group companies.
Mrs Bill graduated from the National University of Singapore with a degree in Pharmacy and later pursued an MBA from the University of Hull in the UK. Previous job experiences include Marketing Executive at Diethelm Singapore Pte Ltd; Product Manager and Marketing Director at Les Laboratoires Servier in Paris, France and Serono as Director of Scientific Affairs in the Asia-Pacific Region and Marketing Director in the International Operations in Switzerland. She joined Debiopharm S.A. in 1998.
Dr. Cicurel received her Licence and Diploma in Medical Biology from the faculty of Medicine of the University of Geneva, Switzerland and then obtained a Masters equivalence as well as a Ph.D. in Biochemistry/Immunology at the University of Illinois, Medical Center, Chicago, US. Previous job experiences include post-graduate research at the Wistar Institute, University of Pennsylvania, Philadelphia and at the National Cancer Institute; 'Chargée de Recherches' at the University of Geneva; Head of Skin and General Pharmacology, Project Manager and then Category Director |
|||||||||
